ARAY Accuray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARAY

Price (delayed)

$2.81

Market cap

$268.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.13

Enterprise value

$407.8M

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation ...

Highlights
ARAY's equity is up by 10% QoQ
The net income has declined by 21% since the previous quarter but it has grown by 4.1% year-on-year
The quick ratio has declined by 16% year-on-year but it has increased by 3.7% since the previous quarter
The EPS has contracted by 18% from the previous quarter
The company's gross profit fell by 6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.accuray.com
Peers: HOLX ICAD SYK

Key stats

What are the main financial stats of ARAY
Market
Shares outstanding
95.49M
Market cap
$268.34M
Enterprise value
$407.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.09
Price to sales (P/S)
0.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
Earnings
Revenue
$417.45M
EBIT
-$8M
EBITDA
-$3M
Free cash flow
-$49.64M
Per share
EPS
-$0.13
Free cash flow per share
-$0.52
Book value per share
$0.55
Revenue per share
$4.41
TBVPS
$4.34
Balance sheet
Total assets
$468.77M
Total liabilities
$417.02M
Debt
$207.38M
Equity
$51.75M
Working capital
$152.23M
Liquidity
Debt to equity
4.01
Current ratio
1.82
Quick ratio
0.85
Net debt/EBITDA
-46.52
Margins
EBITDA margin
-0.7%
Gross margin
37.2%
Net margin
-2.8%
Operating margin
0.5%
Efficiency
Return on assets
-2.5%
Return on equity
-23.2%
Return on invested capital
-2.4%
Return on capital employed
-2.8%
Return on sales
-1.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARAY stock price

How has the Accuray stock price performed over time
Intraday
1.08%
1 week
0.36%
1 month
-1.4%
1 year
-13.8%
YTD
34.45%
QTD
34.45%

Financial performance

How have Accuray's revenue and profit performed over time
Revenue
$417.45M
Gross profit
$155.37M
Operating income
$2.28M
Net income
-$11.82M
Gross margin
37.2%
Net margin
-2.8%
The company's operating margin has shrunk by 85% YoY and by 38% QoQ
The company's operating income has shrunk by 85% YoY and by 36% QoQ
Accuray's net margin has decreased by 22% QoQ
The net income has declined by 21% since the previous quarter but it has grown by 4.1% year-on-year

Growth

What is Accuray's growth rate over time

Valuation

What is Accuray stock price valuation
P/E
N/A
P/B
5.09
P/S
0.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
The EPS has contracted by 18% from the previous quarter
The price to book (P/B) is 18% higher than the last 4 quarters average of 4.3 but 14% lower than the 5-year quarterly average of 5.9
ARAY's equity is up by 10% QoQ
The price to sales (P/S) is 28% higher than the last 4 quarters average of 0.5 but 20% lower than the 5-year quarterly average of 0.8
Accuray's revenue has decreased by 4.5% YoY

Efficiency

How efficient is Accuray business performance
The ROIC has increased by 27% YoY but it has decreased by 14% QoQ
The ROS has grown by 21% YoY but it has contracted by 19% from the previous quarter
Accuray's ROE has decreased by 20% from the previous quarter and by 15% YoY
The company's return on assets fell by 19% QoQ but it rose by 3.8% YoY

Dividends

What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAY.

Financial health

How did Accuray financials performed over time
The company's total assets is 12% higher than its total liabilities
The quick ratio has declined by 16% year-on-year but it has increased by 3.7% since the previous quarter
Accuray's current ratio has increased by 6% YoY and by 4.6% QoQ
ARAY's equity is up by 10% QoQ
The company's debt to equity fell by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.